股本结构
单位：万股
| 公告日期 | 2024-04-22 | 2024-04-15 | 2023-11-09 | 2023-11-13 | 2023-08-10 | 2023-05-10 |
|---|---|---|---|---|---|---|
| 证券总股本 | 3435.53 | 3433.88 | 3187.71 | 3046.68 | 2846.68 | 2833.85 |
| 普通股本 | 3435.53 | 3433.88 | 3187.71 | 3046.68 | 2846.68 | 2833.85 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-04-22 | 2024-04-15 | 2023-11-09 | 2023-09-30 | 2023-06-30 | 2023-05-10 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-04-22 | 3435.53 | 未披露 | 定期报告 | 2024-04-22 |
| 2024-04-15 | 3433.88 | 未披露 | 定期报告 | 2024-04-15 |
| 2023-11-09 | 3187.71 | 未披露 |
更多>>
Common Stock offered 1,410,256 shares by the company.
|
2023-11-09 |
| 2023-11-13 | 3046.68 | 未披露 |
更多>>
From July 1, 2023 to September 30, 2023
Issuance of shares
|
2023-09-30 |
| 2023-08-10 | 2846.68 | 未披露 |
更多>>
From April 1, 2023 to June 30, 2023
Issuance of Shares due to exercise of warrants
|
2023-06-30 |
| 2023-05-10 | 2833.85 | 未披露 | 定期报告 | 2023-05-10 |
| 2023-04-21 | 2792.73 | 未披露 | 定期报告 | 2023-04-12 |
| 2023-05-10 | 2786.15 | 未披露 |
更多>>
From January 1, 2023 to March 31, 2023
Issuance of shares and warrants
Issuance of Shares due to exercise of warrants
|
2023-03-31 |
| 2023-02-24 | 2749.31 | 未披露 |
更多>>
Common stock offered 1,947,368 shares by the company
|
2023-02-27 |
| 2022-08-15 | 2554.58 | 未披露 | 定期报告 | 2022-08-15 |
| 2022-03-30 | 2482.08 | 未披露 | 定期报告 | 2022-03-30 |
| 2022-03-30 | 2428.08 | 未披露 |
更多>>
From January 1, 2020 to December 31, 2021
Stock-based compensation to service providers
Stock-based compensation for Tamir purchase agreement
Exercise of options
Issuance of shares and warrants
Issuance of shares related to acquisition of Koligo
Repurchase of treasury stock
|
2021-12-31 |
| 2021-10-19 | 2427.53 | 未披露 | 定期报告 | 2021-10-19 |
| 2021-08-05 | 2453.74 | 未披露 |
更多>>
From April 1, 2021 to June 30, 2021
Issuance of Shares due to exercise of warrants
Repurchase of treasury stock
|
2021-06-30 |
| 2021-05-06 | 2447.98 | 未披露 | 定期报告 | 2021-05-06 |
| 2021-05-06 | 2446.94 | 未披露 |
更多>>
From January 1, 2021 to March 31, 2021
Exercise of options
Issuance of Shares due to exercise of warrants
Repurchase of treasury stock
|
2021-03-31 |
| 2021-03-26 | 2441.18 | 未披露 | 定期报告 | 2021-03-26 |
| 2021-03-09 | 2419.97 | 未披露 | 定期报告 | 2021-03-09 |
| 2021-03-09 | 2422.31 | 未披露 |
更多>>
From December 31, 2020 to DECEMBER 31, 2020
Stock-based compensation to service providers
Stock-based compensation for Tamir purchase agreement
Exercise of options
Issuance of shares and warrants
Issuance of shares related to acquisition of Koligo
Repurchase of treasury stock
|
2020-12-31 |
| 2020-11-05 | 2415.62 | 未披露 | 定期报告 | 2020-11-05 |
| 2020-08-06 | 2209.45 | 未披露 |
更多>>
From April 1, 2020 to June 30, 2020
Stock-based compensation to service providers
Stock-based compensation for Tamir Purchase Agreement
Exercise of options
|
2020-06-30 |
| 2020-05-08 | 2199.61 | 未披露 | 定期报告 | 2020-05-08 |
| 2020-05-08 | 1836.11 | 未披露 |
更多>>
From January 1, 2020 to March 9, 2020
Stock-based compensation to service providers
Issuance of shares and warrants
|
2020-03-09 |
| 2020-03-09 | 1614.10 | 未披露 |
更多>>
from December 31, 2018 to December 31, 2019
Stock-based compensation to service providers
Stock-based compensation to strategic collaborations
|
2019-12-31 |
| 2019-11-07 | 1616.11 | 未披露 | 定期报告 | 2019-11-07 |
| 2019-11-07 | 1614.10 | 未披露 |
更多>>
from July 1, 2019 to August 8, 2019
Stock-based compensation to service providers
|
2019-08-08 |
| 2019-08-08 | 1611.53 | 未披露 |
更多>>
From January 1, 2019 to May 8, 2019
Stock-based compensation to service providers
Stock based Compensation for JV collaborations
|
2019-05-08 |
| 2019-05-08 | 1610.20 | 未披露 |
更多>>
From January 1, 2019 to March 31, 2019
Stock-based compensation to service providers
Stock based compensation to First Choice
|
2019-03-31 |
| 2019-02-13 | 1562.10 | 未披露 | 定期报告 | 2019-02-13 |
| 2019-02-13 | 1495.18 | 未披露 |
更多>>
From DECEMBER 1, 2017 to NOVEMBER 30, 2018
Stock-based compensation to service providers
Issuance of shares and warrants due to conversion of convertible loans and shares in escrow account
Issuance of shares related to acquisition of Atvio and CureCell
Issuance of shares and warrants and receipts on account of shares to be allotted
Issuance of shares due to exercise of warrants
|
2018-11-30 |
| 2018-10-12 | 1557.10 | 未披露 | 定期报告 | 2018-10-12 |
| 2018-10-12 | 1362.03 | 未披露 |
更多>>
From December 1, 2017 to August 31, 2018
Stock-based compensation to service providers and restricted shares granted to service providers
Issuance of warrants and beneficial conversion feature of convertible loans
Issuance of shares and receipts on account of shares to be allotted related to acquisition of Atvio and CureCell
Issuance of shares and receipts on account of shares to be allotted
Issuance of shares due to exercise of warrants
|
2018-08-31 |
| 2018-09-21 | 1362.05 | 未披露 | 定期报告 | 2018-08-24 |
| 2018-07-17 | 1456.94 | 未披露 | 定期报告 | 2018-07-16 |
| 2018-07-17 | 1330.07 | 未披露 |
更多>>
From December 31, 2017 to May 31, 2018
Issuance of shares and warrant due to conversion of convertible loans
Issuance of shares and receipts on account of shares and warrants to be allotted
Issuance of Shares due to exercise of warrants
|
2018-05-31 |
| 2018-04-16 | 1089.71 | 未披露 | 定期报告 | 2018-04-16 |
| 2018-03-13 | 1026.98 | 未披露 | 定期报告 | 2018-03-13 |
| 2018-04-16 | 1027.33 | 未披露 |
更多>>
from December 1, 2017 to February 28, 2018
Issuance of shares and receipts on account of shares and warrants to be allotted
|
2018-02-28 |
Common Stock offered 1,410,256 shares by the company.
From July 1, 2023 to September 30, 2023
Issuance of shares
From April 1, 2023 to June 30, 2023
Issuance of Shares due to exercise of warrants
From January 1, 2023 to March 31, 2023
Issuance of shares and warrants
Issuance of Shares due to exercise of warrants
Common stock offered 1,947,368 shares by the company
From January 1, 2020 to December 31, 2021
Stock-based compensation to service providers
Stock-based compensation for Tamir purchase agreement
Exercise of options
Issuance of shares and warrants
Issuance of shares related to acquisition of Koligo
Repurchase of treasury stock
From April 1, 2021 to June 30, 2021
Issuance of Shares due to exercise of warrants
Repurchase of treasury stock
From January 1, 2021 to March 31, 2021
Exercise of options
Issuance of Shares due to exercise of warrants
Repurchase of treasury stock
From December 31, 2020 to DECEMBER 31, 2020
Stock-based compensation to service providers
Stock-based compensation for Tamir purchase agreement
Exercise of options
Issuance of shares and warrants
Issuance of shares related to acquisition of Koligo
Repurchase of treasury stock
From April 1, 2020 to June 30, 2020
Stock-based compensation to service providers
Stock-based compensation for Tamir Purchase Agreement
Exercise of options
From January 1, 2020 to March 9, 2020
Stock-based compensation to service providers
Issuance of shares and warrants
from December 31, 2018 to December 31, 2019
Stock-based compensation to service providers
Stock-based compensation to strategic collaborations
from July 1, 2019 to August 8, 2019
Stock-based compensation to service providers
From January 1, 2019 to May 8, 2019
Stock-based compensation to service providers
Stock based Compensation for JV collaborations
From January 1, 2019 to March 31, 2019
Stock-based compensation to service providers
Stock based compensation to First Choice
From DECEMBER 1, 2017 to NOVEMBER 30, 2018
Stock-based compensation to service providers
Issuance of shares and warrants due to conversion of convertible loans and shares in escrow account
Issuance of shares related to acquisition of Atvio and CureCell
Issuance of shares and warrants and receipts on account of shares to be allotted
Issuance of shares due to exercise of warrants
From December 1, 2017 to August 31, 2018
Stock-based compensation to service providers and restricted shares granted to service providers
Issuance of warrants and beneficial conversion feature of convertible loans
Issuance of shares and receipts on account of shares to be allotted related to acquisition of Atvio and CureCell
Issuance of shares and receipts on account of shares to be allotted
Issuance of shares due to exercise of warrants
From December 31, 2017 to May 31, 2018
Issuance of shares and warrant due to conversion of convertible loans
Issuance of shares and receipts on account of shares and warrants to be allotted
Issuance of Shares due to exercise of warrants
from December 1, 2017 to February 28, 2018
Issuance of shares and receipts on account of shares and warrants to be allotted